GTHX

G1 Therapeutics Stock Price

17.60
-0.43 (-2.38%)
Upgrade to Real-Time
Regular Market
17.60

Low
10.81

52 Week Range

High
37.06

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
G1 Therapeutics Inc GTHX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.43 -2.38% 17.60 11:06:12
Open Price Low Price High Price Close Price Prev Close
18.10 17.48 18.18 18.03
Bid Price Ask Price Spread News
17.58 17.63 0.05 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,729 206,596 $ 17.82 $ 3,680,996 - 10.81 - 37.06
Last Trade Time Type Quantity Stock Price Currency
11:06:08 50 $ 17.5998 USD

Period:

Draw Mode:

G1 Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 740.51M 42.07M 41.80M $ 45.29M $ - -2.63 -7.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 57.37k 2.30%

more financials information »

G1 Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GTHX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week19.1019.2217.4818.282,145,497-1.50-7.85%
1 Month23.2924.1217.4819.691,526,869-5.69-24.43%
3 Months21.8324.1217.4820.671,225,032-4.23-19.38%
6 Months21.0037.0617.4823.111,346,258-3.40-16.19%
1 Year18.7337.0610.8120.071,173,319-1.13-6.03%
3 Years47.2969.578.8022.48649,788-29.69-62.78%
5 Years15.0069.578.8023.47520,0182.6017.33%

G1 Therapeutics Description

G1 Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat most types of cancer such as cell lung cancer and breast cancer and designs them to combine - and enhance - the anti-tumor activity of current therapies.


Your Recent History
NASDAQ
GTHX
G1 Therape..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.